[1] 季宇彬. 抗癌中药药理与应用[M]. 哈尔滨:黑龙江科技出版社,1992:1154-1156. [2] 王立新,何海冰,唐 星,等. 去甲基斑蝥酸钠脂质微球体内外评价[J]. 药学学报,2006;41(8):784-788. [3] Bei YY,Chen XY,Liu Y,et al. Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorption[J]. Int J Nanomed,2012,(7):1819-1827. [4] 安中原,王 正,赵 越. 斑蝥素及其衍生物的抗肿瘤研究进展[J]. 亚太传统医药,2009,5(1):128-130. [5] 张卫东,赵惠儒,于秉治,等. 斑蝥素通过MAPK途径对肺癌A549细胞周期阻滞及其分子机制的研究[J]. 中国医科大学学报,2006,35(4):382-384. [6] 王晓华,马 萍,尹元琴,等. 斑蝥素对A549细胞增殖抑制作用的研究[J]. 沈阳药科大学学报,2006,23(9):598-601. [7] Lee YC,Lee LM,Yang CH,et al. Norcantharidin suppresses cell growth and migration with enhanced anticancer activity of gefitinib and cisplatin in human non-small cell lung cancer cells[J]. Oncol Rep,2013,29(1):237-243. [8] Hsieh CH,Chao KS,Liao HF,et al. Norcantharidin, derivative of cantharidin,for cancer stem cells[J]. Evid-Based Compl Alt,2013:838651 [9] Wang H,Sun W,Zhang WZ,et al. Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway[J]. PLoS One,2014,9(5):96982. [10] Zhang JT,Sun W,Zhang WZ,et al. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway[J]. BMC Cancer,2014,15(14):193. [11] Luan J,Duan H,Liu Q,et al. Inhibitory effects of norcantharidin against human lung cancer cell growth and migration[J]. Cytotechnology,2010,62(4):349-355. [12] 崔宝弟,王 敏,孙震晓. 去甲斑蝥素对人肺腺癌A549细胞的抑制作用[J]. 癌变·畸变·突变,2015,27(1):21-25. [13] 魏方超,杜 娟,未宁宁. 等. 斑蝥素及其衍生物的研究现状与应用[J]. 现代生物医学进展,2012,12(8):1586-1589. [14] 李增云,马庆彤,张 燕,等. 健择与顺铂联合去甲斑蝥酸钠治疗晚期NSCLC疗效观察[J]. 中华肿瘤防治杂志,2014, 21(4):293-295. [15] 管志峰. 去甲斑蝥酸钠辅助治疗晚期非小细胞肺癌50例临床观察[J]. 齐齐哈尔医学院院报,2010,31(17):2727. [16] Chen YJ,Tsai YM,Kuo CD,et al. Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect[J]. Life Sci,2009,85(17/18):642-651. [17] 陈素秀,蒋亦燕,费正华. 去甲斑蝥酸钠对耐顺铂肺腺癌A549/DDP细胞的逆转作用及机制[J]. 中华老年医学杂志,2010,29(6):486-488. [18] 陈小蕾,吴立强,赵 青. 斑蝥酸钠注射液致喉头水肿[J]. 中国药物应用与监测,2013,10(3):183-184. [19] 陆立芳,杨 萍. 斑蝥酸钠注射液在治疗肿瘤患者输液时的临床观察及护理[J]. 中国社区医师,2012,14(33):261-262. [20] 何海冰,景士云,王 娟,等. 去甲斑蝥酸钠脂质微球在大鼠体内的组织分布[J]. 沈阳药科大学学报,2007,24(8): 461-464. [21] 邵瑞莹. 去甲基斑蝥素脂质微球注射液的研究[D]. 沈阳:沈阳药科大学,2005:2,61-67. [22] 许凉凉,伊 辛,戎 堃,等. 微球载体材料研究概况及其在中药领域的展望[J]. 中国实验方剂学杂志,2014, 20(10):239-242. |